TP53 and neoplasm: Examination of the copy number profile of the relapsed sample of ACP11 relative to the primary tumour sample revealed several CNVs including the acquisition of a deletion of TP53 (Fig. 3C), which was further confirmed as heterozygous by next-generation sequencing.